The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis
Abstract
Malignant mesothelioma (MM) is an aggressive cancer arising from mesothelial cells, mainly due to former asbestos exposure. Little is known about the microRNA (miRNA) expression of MM. miRNAs are small noncoding RNAs, which play an essential role in the regulation of gene expression. This study was carried out to analyze the miRNA expression profile of 17 MM samples using miRNA microarray. The analysis distinguished the overall miRNA expression profiles of tumor tissue and normal mesothelium. Differentially expressed miRNAs were found in tumor samples compared with normal sample. Twelve of them, let‐7b*, miR‐1228*, miR‐195*, miR‐30b*, miR‐32*, miR‐345, miR‐483‐3p, miR‐584, miR‐595, miR‐615‐3p, and miR‐885‐3p, were highly expressed whereas the remaining nine, let‐7e*, miR‐144*, miR‐203, miR‐340*, miR‐34a*, miR‐423, miR‐582, miR‐7‐1*, and miR‐9, were unexpressed or had severely reduced expression levels. Target genes for these miRNAs include the most frequently affected genes in MM such as CDKN2A, NF2, JUN, HGF, and PDGFA. Many of the miRNAs were located in chromosomal areas known to be deleted or gained in MM such as 8q24, 1p36, and 14q32. Furthermore, we could identify specific miRNAs for each histopathological subtype of MM. Regarding risk factors such as smoking status and asbestos exposure, significantly differentially expressed miRNAs were identified in smokers versus nonsmokers (miR‐379, miR‐301a, miR‐299‐3p, miR‐455‐3p, and miR‐127‐3p), but not in asbestos‐exposed patients versus nonexposed ones. This could be related to the method of assessment of asbestos exposure as asbestos remains to be the main contributor to the development of MM. © 2009 Wiley‐Liss,Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
miRBase: tools for microRNA genomics
Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,382
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,581
MicroRNAs in cell proliferation, cell death, and tumorigenesis
Hwang, H.-W., & Mendell, J. T. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603023 · Cited by 1,399
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Asbestos: Scientific Developments and Implications for Public Policy
Mossman, B. T., Bignon, J., Corn, M., Seaton, A., & Gee, J. B. L. (1990) · Science · doi:10.1126/science.2153315 · Cited by 742
MicroRNA Expression Profiles in Serous Ovarian Carcinoma
Nam, E. J., Yoon, H., Kim, S. W., Kim, H., Kim, Y. T., Kim, J. H., Kim, J. W., & Kim, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1731 · Cited by 740
Landi, M. T., Dracheva, T., Rotunno, M., Figueroa, J. D., Liu, H., Dasgupta, A., Mann, F. E., Fukuoka, J., Hames, M., Bergen, A. W., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001651 · Cited by 680
Mossman, B. T., & Gee, J. B. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202604 · Cited by 497
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450
The pathogenesis of mesothelioma
Carbone, M., Kratzke, R. A., & Testa, J. R. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.30227 · Cited by 392
MicroRNA expression profiles of esophageal cancer
Feber, A., Xi, L., Luketich, J. D., Pennathur, A., Landreneau, R. J., Wu, M., Swanson, S. J., Godfrey, T. E., & Litle, V. R. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.08.055 · Cited by 382
Direct and sensitive miRNA profiling from low-input total RNA
Wang, H., Ach, R. A., & Curry, B. (2007) · RNA · doi:10.1261/rna.234507 · Cited by 302
Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90162-0 · Cited by 296
Flores, R. M., Zakowski, M., Venkatraman, E., Krug, L., Rosenzweig, K., Dycoco, J., Lee, C., Yeoh, C., Bains, M., & Rusch, V. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815608d9 · Cited by 229
Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma
Jagadeeswaran, R., Ma, P. C., Seiwert, T. Y., Jagadeeswaran, S., Zumba, O., Nallasura, V., Ahmed, S., Filiberti, R., Paganuzzi, M., Puntoni, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4567 · Cited by 198
Mechanisms of Carcinogenesis and Clinical Features of Asbestos-Associated Cancers
Mossman, B. T., Kamp, D. W., & Weitzman, S. A. (1996) · Cancer Investigation · doi:10.3109/07357909609018904 · Cited by 197
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
Wagner, J. C., Sleggs, C. A., & Marchand, P. (1960) · Occupational and Environmental Medicine · doi:10.1136/oem.17.4.260 · Cited by 182
Fabbri, M., Croce, C. M., & Calin, G. A. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e318164145e · Cited by 180
Poulikakos, P. I., Xiao, G.-H., Gallagher, R., Jablonski, S., Jhanwar, S. C., & Testa, J. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209587 · Cited by 178
Cury, P. M., Butcher, D. N., Fisher, C., Corrin, B., & Nicholson, A. G. (2000) · Modern Pathology · doi:10.1038/modpathol.3880018 · Cited by 165
Self-citationRegulatory mechanisms of microRNAs involvement in cancer: the strange case of Dr Jekyll and Mr Hyde
Fabbri, M., Ivan, M., Cimmino, A., Negrini, M., & Calin, G. A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1009 · Cited by 164
Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma
Pass, H. I., Liu, Z., Wali, A., Bueno, R., Land, S. J., Lott, D., Siddiq, F., Lonardo, F., Carbone, M., & Drăghici, S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0607-3 · Cited by 123
Taniguchi, T., Karnan, S., Fukui, T., Yokoyama, T., Tagawa, H., Yokoi, K., Ueda, Y., Mitsudomi, T., Horio, Y., Hida, T., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2006.00386.x · Cited by 91
Björkqvist, A.-M., Tammilehto, L., Anttila, S. L., Mattson, K. V., & Knuutila, S. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.91 · Cited by 88
Self-citationNonrandom chromosomal abnormalities in malignant pleural mesothelioma
Tiainen, M., Tammilehto, L., Mattson, K. V., & Knuutila, S. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90035-0 · Cited by 77
Self-citationBalsara, B., Bell, D. W., Sonoda, G., Rienzo, A. D., du Manoir, S., Jhanwar, S. C., & Testa, J. R. (1999) · PubMed · Cited by 77
Genomic events associated with progression of pleural malignant mesothelioma
Ivanov, S. V., Miller, J., Lucito, R., Tang, C., Ivanova, A. V., Pei, J., Carbone, M., Cruz, C., Beck, A. K., Webb, C. P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23949 · Cited by 76
Problems in mesothelioma diagnosis
Addis, B. J., & Roche, H. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03178.x · Cited by 75
Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH
Lindholm, P., Salmenkivi, K., Vauhkonen, H., Nicholson, A. G., Anttila, S. L., Kinnula, V. L., & Knuutila, S. (2007) · Cytogenetic and Genome Research · doi:10.1159/000109618 · Cited by 73
Self-citationKrismann, M., Müller, K., Jaworska, M., & Johnen, G. (2002) · The Journal of Pathology · doi:10.1002/path.1128 · Cited by 66
Smoking-related Genomic Signatures in Non–Small Cell Lung Cancer
Massion, P. P., Zou, Y., Chen, H., Jiang, A., Coulson, P., Amos, C. I., Wu, X., Wistuba, I. I., Wei, Q., Shyr, Y., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-142oc · Cited by 49
Metheny‐Barlow, L. J., Flynn, B. J., van Gijssel, H. E., Marrogi, A. J., & Gerwin, B. I. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4334 · Cited by 34
Asbestos Burden Predicts Survival in Pleural Mesothelioma
Christensen, B. C., Godleski, J. J., Roelofs, C. R., Longacker, J. L., Bueno, R., Sugarbaker, D. J., Marsit, C. J., Nelson, H. H., & Kelsey, K. T. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11151 · Cited by 33
Advances in the molecular biology of malignant mesothelioma.
Toyooka, S., Kishimoto, T., & Date, H. (2008) · PubMed · doi:10.18926/amo/30990 · Cited by 33
Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma
Rienzo, A. D., Jhanwar, S. C., & Testa, J. R. (2000) · Genes Chromosomes and Cancer · Cited by 30
Cited by
Advances in multiplexed techniques for the detection and quantification of microRNAs
Jet, T., Gines, G., Rondelez, Y., & Taly, V. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00609b · Cited by 453
miRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma
Jones, K. B., Salah, Z., Del Mare, S., Galasso, M., Gaudio, E., Nuovo, G. J., Lovat, F., LeBlanc, K., Palatini, J., Randall, R. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2663 · Cited by 363
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., & He, X. (2010) · Oncogene · doi:10.1038/onc.2010.34 · Cited by 346
Molecular pathogenesis of malignant mesothelioma
Sekido, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt166 · Cited by 279
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
Reid, G., Pel, M. E., Kirschner, M. B., Cheng, Y. Y., Mugridge, N., Weiss, J., Williams, M., Wright, C., Edelman, J. J. B., Vallely, M. P., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt412 · Cited by 275
Metadata
- Authors
- Guled, M., Lahti, L., Lindholm, P. M., Salmenkivi, K., Bagwan, I., Nicholson, A. G., & Knuutila, S.
- Venue
- Genes, Chromosomes and Cancer
- Publisher
- Wiley
- Published
- 2009-04-24
- Volume
- 48
- Issue
- 7
- Pages
- 615-623
- ISSN
- 1045-2257 (ISSN-L)
- 1098-2264
- OpenAlex
- W2167906380
- Cited by
- 259
- References
- 46
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.